Show simple item record

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

dc.contributor.authorSaag, Kenneth G.
dc.contributor.authorTeng, Gim Gee
dc.contributor.authorPatkar, Nivedita M.
dc.contributor.authorAnuntiyo, Jeremy
dc.contributor.authorFinney, Catherine
dc.contributor.authorCurtis, Jeffrey R.
dc.contributor.authorPaulus, Harold
dc.contributor.authorMudano, Amy S.
dc.contributor.authorPisu, Maria
dc.contributor.authorElkins-Melton, Mary
dc.contributor.authorOutman, Ryan
dc.contributor.authorAllison, Jeroan J.
dc.contributor.authorSuarez Almazor, Maria
dc.contributor.authorBridges, S. Louis Jr.
dc.contributor.authorChatham, W. Winn
dc.contributor.authorHochberg, Marc
dc.contributor.authorMacLean, Catherine H.
dc.contributor.authorMikuls, Ted R.
dc.contributor.authorMoreland, Larry W.
dc.contributor.authorO'Dell, James
dc.contributor.authorTurkiewicz, Anthony M.
dc.contributor.authorFurst, Daniel E.
dc.date2022-08-11T08:10:43.000
dc.date.accessioned2022-08-23T17:17:44Z
dc.date.available2022-08-23T17:17:44Z
dc.date.issued2008-06-03
dc.date.submitted2010-08-05
dc.identifier.citationArthritis Rheum. 2008 Jun 15;59(6):762-84. <a href="http://dx.doi.org/10.1002/art.23721">Link to article on publisher's site</a>
dc.identifier.issn0004-3591 (Linking)
dc.identifier.doi10.1002/art.23721
dc.identifier.pmid18512708
dc.identifier.urihttp://hdl.handle.net/20.500.14038/47698
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=18512708&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1002/art.23721
dc.subjectAntirheumatic Agents
dc.subjectArthritis, Rheumatoid
dc.subjectBiological Products
dc.subject*Health Planning Guidelines
dc.subjectHumans
dc.subjectBioinformatics
dc.subjectBiostatistics
dc.subjectEpidemiology
dc.subjectHealth Services Research
dc.titleAmerican College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
dc.typeJournal Article
dc.source.journaltitleArthritis and rheumatism
dc.source.volume59
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/qhs_pp/822
dc.identifier.contextkey1426296
dc.identifier.submissionpathqhs_pp/822
dc.contributor.departmentDepartment of Quantitative Health Sciences
dc.source.pages762-84


This item appears in the following Collection(s)

Show simple item record